Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.020 -0.060 (-1.95%)

Delayed Quote Updated: 2:04 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

22 23 Next >

Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive ↗

December 07, 2022

In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount...

Via Benzinga

EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In November 2022: Where Do Tesla, Apple, A Donald Trump-Linked SPAC Rank? ↗

December 05, 2022

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Via Benzinga

3 Biotech Stocks Smart Investors Should Be Buying Up Now ↗

November 24, 2022

These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.

Via InvestorPlace

Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday ↗

November 23, 2022

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

FDA Signals Unclear Clinical Benefits Of Ardelyx's Kidney Disease Candidate ↗

November 14, 2022

Via Benzinga

Is Ardelyx is A Buy After Slip in Early 2022

November 21, 2022

Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them

Via MarketBeat

CapitalGainsReport Sector Spotlight: Healthcare Penny Stocks On The Move (ARDX, WHSI, BNGO)

November 21, 2022

Via AB Newswire

Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday ↗

November 21, 2022

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.

Via Benzinga

Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday ↗

November 21, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street ↗

November 20, 2022

Recent analyst upgrades suggest these stocks can triple your money or better.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 18, 2022

Via Benzinga

Analyst Sees This Kidney Disease Company's Stock Could Rise Sixfold, But Lists Two Issues ↗

November 18, 2022

Via Benzinga

Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

November 18, 2022

Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.

Via Benzinga

Hillenbrand, Cisco, Macy's And Other Big Gainers From Thursday ↗

November 18, 2022

U.S. stocks closed slightly lower on Thursday, with the S&P 500 dropping around 0.3%. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday ↗

November 18, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 17, 2022

Via Benzinga

Nasdaq Down 60 Points; Alibaba Posts Upbeat Q2 Earnings ↗

November 17, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 60 points on Thursday.

Via Benzinga

Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session ↗

November 17, 2022

Gainers Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67...

Via Benzinga

Fed Comments Continue To Weigh On Stocks Midday ↗

November 17, 2022

Stocks are firmly lower midday, as bond yields rise following hawkish comments from St. Louis Federal Reserve President James Bullard.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 17, 2022

Via Benzinga

Looking Into Ardelyx's Recent Short Interest ↗

November 17, 2022

Ardelyx's (NASDAQ:ARDX) short percent of float has fallen 23.89% since its last report. The company recently reported that it has 7.34 million shares sold short, which is 3.95% of all regular shares...

Via Benzinga

S&P 500 Down 1%; Crude Oil Drops Sharply ↗

November 17, 2022

U.S. stocks traded lower midway through trading, with the S&P 500 dropping around 1% on Thursday.

Via Benzinga

Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today? ↗

November 17, 2022

CytomX Therapeutics (CTMX) stock is rising higher on Wednesday after announcing a partnership with Regeneron Pharmaceuticals (REGN).

Via InvestorPlace

Why Is Ardelyx (ARDX) Stock Up 38% Today? ↗

November 17, 2022

Ardelyx (ARDX) stock is taking off on Thursday after an advisory committee to the FDA voted in favor of its kidney disease drug.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗

November 17, 2022

Upgrades

Via Benzinga

Ukraine Asserts It Does Not Take Blame For Poland Missile Attack, Crypto Exchange Gemini Suffers $485M In Outflows, FTX, Bahamas Regulator Lock Horns Over Control Of Bankruptcy Proceedings: Top Stories Thursday, Nov. 17 ↗

November 17, 2022

CNBC

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 17, 2022

Via Benzinga

Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket ↗

November 17, 2022

Gainers

Via Benzinga

Despite Concerns, FDA Advisory Committee Votes In Favor Of Ardelyx's Kidney Disease Candidate ↗

November 17, 2022

Via Benzinga

Cisco, Bath & Body Works And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 17, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.